TSWM
CODX

Tyler-Stone Wealth Management’s Co-Diagnostics CODX Stock Holding History

Tyler-Stone Wealth Management’s Portfolio CODX Stock Details CODX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$3K Hold
34
– – ﹤0.01% 708
2022
Q3 		$3K Hold
34
– – ﹤0.01% 702
2022
Q2 		$6K Sell
34
-13
-28% -$1.98K ﹤0.01% 627
2022
Q1 		$9K Sell
47
-2
-4% -$414 ﹤0.01% 588
2021
Q4 		$13K Buy
+49
New +$12.9K 0.01% 557

Other funds holding CODX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
EIP
Easterly Investment Partners Beverly, Massachusetts $1.97B AUM 25.87% 1-Year Est. Return

Tyler-Stone Wealth Management's CODX Position: Q4 2022 in Review

Tyler-Stone Wealth Management held its Co-Diagnostics (CODX) position steady in Q4 2022 at 34 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #708.

Tyler-Stone Wealth Management first reported a position in CODX in Q4 2021 and has held it in 5 quarters since. The position peaked at $13K in Q4 2021. 60 funds tracked by Wall St. Rank hold CODX as of Q4 2022.

  • Tyler-Stone Wealth Management held 34 shares of Co-Diagnostics worth $3K as of Q4 2022.
  • Tyler-Stone Wealth Management left its Co-Diagnostics share count unchanged in Q4 2022.
  • Co-Diagnostics made up ﹤0.01% of Tyler-Stone Wealth Management's portfolio in Q4 2022, its #708 holding.
  • Tyler-Stone Wealth Management first reported a position in Co-Diagnostics in Q4 2021 and has held it in 5 quarters since.
  • Tyler-Stone Wealth Management's Co-Diagnostics position peaked at $13K in Q4 2021.
  • 60 funds tracked by Wall St. Rank held Co-Diagnostics as of Q4 2022.

Based on Tyler-Stone Wealth Management's 13F filing for Q4 2022, filed 14 Feb 2023.